CBD provider to pay $363,000 for false advertising claims
Article content The claims in question included that, “cannabidiol can change gene expression and remove beta-amyloid plaque, the hallmark of Alzheimer’s, from brain cells” and that “scientific and clinical studies have shown that CBD could be therapeutic for many conditions.” That long list of these conditions includes chronic pain, cancer, diabetes, sleep disorders, rheumatoid arthritis, post-traumatic stress disorder, alcoholism and neurological ailments, notes the SCDAO release. As a member of the California Food, Drug and Medical Device Task Force, the SCDAO and CannaCraft reac...